z-logo
open-access-imgOpen Access
Analysis of the Level of IgG to SARS-CoV-2 Virus and Molecular Markers of Activation of CD25, CD54 (ICAM-1) and CD95 Lymphocytes in the Patients Who were Not Ill with COVID-19, Recovered from COVID-19 and Who had Acute Respiratory Infections. The Results of the Correction of Impaired Immune Homeostasis Using the Multitarget Immunotherapy Drug Mercureid
Author(s) -
Gusev SN
Publication year - 2022
Language(s) - English
DOI - 10.46889/jcim.2022.3304
Subject(s) - immunology , asymptomatic , antibody , virus , immune system , medicine , virology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom